{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:16:54Z","timestamp":1788524214695,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.josat.2025.209808","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:01:25Z","timestamp":1758085285000},"page":"209808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Feasibility of direct induction onto long-acting injectable buprenorphine"],"prefix":"10.1016","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0887-3696","authenticated-orcid":false,"given":"Thileepan","family":"Naren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Membrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"MacCartney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"D'Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5341-1055","authenticated-orcid":false,"given":"Suzanne","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.josat.2025.209808_bb0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.31128\/AJGP-07-21-6098","article-title":"Retention rates with monthly depot buprenorphine in general practice in Melbourne, Australia","volume":"51","author":"Andrada","year":"2022","journal-title":"Australian Journal of General Practice"},{"key":"10.1016\/j.josat.2025.209808_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajem.2024.11.031","article-title":"Initiation of buprenorphine in the emergency department or emergency out-of-hospital setting: A mixed-methods systematic review","volume":"88","author":"Armour","year":"2025","journal-title":"The American Journal of Emergency Medicine"},{"key":"10.1016\/j.josat.2025.209808_bb0015","series-title":"Australian product information\u2014Buvidal\u00ae weekly and Buvidal\u00ae monthly (buprenorphine) [Online]","year":"2023"},{"key":"10.1016\/j.josat.2025.209808_bb0020","series-title":"Australian product information\u2014Sublocade (buprenorphine) [Online]","year":"2023"},{"key":"10.1016\/j.josat.2025.209808_bb0025","unstructured":"Best Practice Software. (n.d.). Bp Software. Retrieved April 6, 2025, from https:\/\/bpsoftware.net\/."},{"issue":"4","key":"10.1016\/j.josat.2025.209808_bb0030","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/add.12834","article-title":"A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia","volume":"110","author":"Burns","year":"2015","journal-title":"Addiction (Abingdon, England)"},{"key":"10.1016\/j.josat.2025.209808_bb0035","unstructured":"Dean, A., Sullivan, K., & Soe, M. (n.d.). OpenEpi: Open source epidemiologic statistics for public health, version 2.3.1 \u2013 ScienceOpen. Retrieved February 22, 2025, from https:\/\/www.scienceopen.com\/book?vid=61cdd360-9883-4330-8c18-3f0341b0f715."},{"key":"10.1016\/j.josat.2025.209808_bb0040","series-title":"Long acting injectable buprenorphine","author":"Department of Health. Victoria","year":"2020"},{"issue":"7","key":"10.1016\/j.josat.2025.209808_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.20702","article-title":"Extended-release 7-day injectable buprenorphine for patients with minimal to mild opioid withdrawal","volume":"7","author":"D\u2019Onofrio","year":"2024","journal-title":"JAMA Network Open"},{"issue":"12","key":"10.1016\/j.josat.2025.209808_bb0050","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/acem.14782","article-title":"Early emergency department experience with 7-day extended-release injectable buprenorphine for opioid use disorder","volume":"30","author":"D\u2019Onofrio","year":"2023","journal-title":"Academic Emergency Medicine"},{"issue":"1","key":"10.1016\/j.josat.2025.209808_bb0055","first-page":"7","article-title":"Buprenorphine induction and stabilisation in the treatment of opiate dependence","volume":"7","author":"Doran","year":"2005","journal-title":"Heroin Addiction and Related Clinical Problems"},{"key":"10.1016\/j.josat.2025.209808_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103492","article-title":"Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence","volume":"100","author":"Farrell","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209808_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104390","article-title":"96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial","volume":"127","author":"Farrell","year":"2024","journal-title":"The International Journal on Drug Policy"},{"issue":"8","key":"10.1016\/j.josat.2025.209808_bb0070","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/add.14636","article-title":"Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder","volume":"114","author":"Frost","year":"2019","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2025.209808_bb0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13722-019-0139-3","article-title":"Provider and patient perspectives on barriers to buprenorphine adherence and the acceptability of video directly observed therapy to enhance adherence","volume":"14","author":"Godersky","year":"2019","journal-title":"Addiction Science & Clinical Practice"},{"issue":"7","key":"10.1016\/j.josat.2025.209808_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.17128","article-title":"High-dose buprenorphine induction in the emergency department for treatment of opioid use disorder","volume":"4","author":"Herring","year":"2021","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2025.209808_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.12.021","article-title":"Opioid substitution therapy: Lowering the treatment thresholds","volume":"161","author":"Kourounis","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.josat.2025.209808_bb0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ADM.0000000000001300","article-title":"Higher first 30-day dose of buprenorphine for opioid use disorder treatment is associated with decreased mortality","volume":"18","author":"Lei","year":"2024","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.josat.2025.209808_bb0095","series-title":"Long-acting injectable buprenorphine (LAIB) for opioid dependence treatment: Practice guide","author":"Lintzeris","year":"2024"},{"issue":"6","key":"10.1016\/j.josat.2025.209808_bb0100","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5694\/mja2.52250","article-title":"The uptake of long-acting depot buprenorphine for treating opioid dependence in Australia, 2019\u20132022: Longitudinal sales data analysis","volume":"220","author":"Lintzeris","year":"2024","journal-title":"Medical Journal of Australia"},{"issue":"4","key":"10.1016\/j.josat.2025.209808_bb0105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/ajad.13018","article-title":"Case series: Rapid induction onto long acting buprenorphine injection for high potency synthetic opioid users","volume":"29","author":"Mariani","year":"2020","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2025.209808_bb0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajp.2019.07.030","article-title":"\u2018Too little dose \u2013 Too early discontinuation?\u2019\u2014Effect of buprenorphine dose on short term treatment adherence in opioid dependence","volume":"44","author":"Muruganandam","year":"2019","journal-title":"Asian Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.josat.2025.209808_bb0115","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/10398562241237655","article-title":"Direct induction onto high-dose long-acting injectable buprenorphine: A case series","volume":"32","author":"Naren","year":"2024","journal-title":"Australas Psychiatry"},{"issue":"3","key":"10.1016\/j.josat.2025.209808_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jsat.2011.12.009","article-title":"Comparing buprenorphine induction experience with heroin and prescription opioid users","volume":"43","author":"Nielsen","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"4","key":"10.1016\/j.josat.2025.209808_bb0125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/dar.13161","article-title":"The development and implementation of a rapid-access long-acting injectable buprenorphine clinic in metropolitan Melbourne during the COVID-19 pandemic","volume":"40","author":"Straub","year":"2021","journal-title":"Drug and Alcohol Review"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925001870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:29:22Z","timestamp":1767914962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925001870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":25,"alternative-id":["S2949875925001870"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209808","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of direct induction onto long-acting injectable buprenorphine","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209808","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209808"}}